Primary Care Clinics in Roscommon, MI Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Midmichigan Health Services Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 112 S 4th St, Ste Medical, Roscommon, MI 48653 Phone: 989-422-5122 Fax: 989-422-4378 |
Village Family Medicine Pc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 308b Lake St, Roscommon, MI 48653 Phone: 989-302-2360 |
Midmichigan Health Services Gerrish Higgins Community Schools Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 299 E Sunset Dr, Roscommon, MI 48653 Phone: 989-275-6640 Fax: 989-275-4074 |
Roscommon Community Health Center Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 234 Lake St, Roscommon, MI 48653 Phone: 989-275-1200 |
Midmichigan Medical Offices - Roscommon Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 135 Lake St, Roscommon, MI 48653 Phone: 989-275-8931 Fax: 989-275-4074 |
News Archive
Latest research findings on autism to be discussed in Seattle
More than 900 scientists, parents and activists from around the world who are focused on understanding the causes of autism and finding treatments for the developmental disorder will gather in Seattle May 3-5 to share the latest research findings at the sixth annual International Meeting for Autism Research.
Center for Reproductive Rights releases 2011 map of World's Abortion Laws
The Center for Reproductive Rights has released its online World's Abortion Laws map for 2011. The center has produced the map since 1998 "to visually compare the legal status of induced abortion in different countries - and to advocate for greater progress in ensuring access to safe and legal abortion services for all women worldwide."
FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
C-section delivery, early antibiotic treatment linked to eosinophilic esophagitis in children
Children delivered by cesarean section and those given antibiotics during early infancy appear more prone to developing allergic inflammation of the esophagus — the muscular tube that connects the mouth to the stomach — according to results of a study by investigators from the Johns Hopkins Children's Center and Harvard Medical School.
› Verified 2 days ago